Komori
Papyless (3641) · InitiativeDecrease in outstanding balance due to expiration and exercise of rights

Granting Stock Options to Employees

First written in FY2022-Q1. 1 of 5 entries say "Advanced", first in FY2024. Latest entry: FY2025.

5entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q1 – FY2023AdvancedFY20242021: 120212022: 120222023: 120232024: 120242025: 12025
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 654 companies write about · 0 as a headwind · 735 as a tailwind

18 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 737 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025Decrease in outstanding balance due to expiration and exercise of rightsAnnual report

    「June 2021 stock options; end of previous consolidated fiscal year: 22,000; expired: 1,000; unexercised balance: 21,000」

    Of the stock options granted in June 2021, 1,000 shares expired, reducing the unexercised balance from 22,000 shares at the end of the previous fiscal year to 21,000 shares. Of the options granted in June 2014, 48,000 shares were exercised.
  2. FY2024AdvancedAnnual report

    「June 2021 stock options; after vesting: end of previous consolidated fiscal year: —; vested: 22,000; exercised: —; unexercised balance: 22,000」

    Of the stock options granted in June 2021, 500 shares expired from the unvested balance of 22,500 shares at the end of the previous fiscal year, and 22,000 shares vested. Of the options granted in June 2014, 8,000 shares were exercised.
  3. FY2023Decrease in outstanding grants due to expiration of rightsAnnual report

    「End of previous consolidated fiscal year: 25,500; expired: 3,000; outstanding but not yet vested: 22,500」

    The stock options granted in June 2021 decreased from 25,500 shares to 22,500 shares due to expiration of rights.
  4. FY2022Decrease in outstanding grants due to expiration of rightsAnnual report

    「15 June 2021; category and number of grantees (people): employees, 34; number of stock acquisition rights (units): 255; class, description and number of shares underlying the stock acquisition rights (shares): common shares, 25,500」

    The number of grantees, stock acquisition rights and underlying shares decreased from 37 people, 270 rights and 27,000 shares as of FY2022-Q1 to 34 people, 255 rights and 25,500 shares due to expiration of rights and other factors.
  5. FY2022-Q1First statedAnnual report

    「Resolution date: 15 June 2021; category and number of grantees (people): employees of the Company, 37; number of stock acquisition rights (units): 270; class, description and number of shares underlying the stock acquisition rights (shares): common shares, 27,000; exercise price of the stock acquisition rights (yen): 1,706; exercise period: from 1 July 2023 to 14 June 2031」

    The terms of the stock option plan are disclosed. The plan grants 270 stock acquisition rights, representing 27,000 common shares, to 37 employees of the Company, with an exercise period from 1 July 2023 to 14 June 2031.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Papyless yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Granting Stock Options to Employees | PAPYLESS CO.,LTD. (3641) | Komori